Republic of Korea: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Republic of Korea

The South Korean human and animal blood market expanded sharply to $X in 2022, surging by X% against the previous year. The market value increased at an average annual rate of X% from 2012 to 2022; the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, consumption attained the peak level of $X. From 2021 to 2022, the growth of the market remained at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Republic of Korea

In value terms, human and animal blood production expanded remarkably to $X in 2022 estimated in export price. In general, the total production indicated tangible growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The growth pace was the most rapid in 2020 with an increase of X%. As a result, production attained the peak level of $X. From 2021 to 2022, production growth remained at a somewhat lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Republic of Korea

In 2022, exports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses from South Korea dropped sharply to X tons, waning by X% on 2021 figures. Over the period under review, exports showed a mild curtailment. The most prominent rate of growth was recorded in 2016 when exports increased by X%. The exports peaked at X tons in 2019; however, from 2020 to 2022, the exports remained at a lower figure.

In value terms, human and animal blood exports declined sharply to $X in 2022. Overall, exports, however, enjoyed a strong expansion. The most prominent rate of growth was recorded in 2017 with an increase of X%. The exports peaked at $X in 2021, and then declined sharply in the following year.

Exports by Country

Vietnam (X tons), the United States (X tons) and Japan (X tons) were the main destinations of human and animal blood exports from South Korea, together comprising X% of total exports. China, Mexico, Bangladesh, Thailand, Indonesia, India, Costa Rica, the United Arab Emirates, Brazil and the Philippines lagged somewhat behind, together comprising a further X%.

From 2012 to 2022, the biggest increases were recorded for Costa Rica (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X) emerged as the key foreign market for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports from South Korea, comprising X% of total exports. The second position in the ranking was held by Brazil ($X), with a X% share of total exports. It was followed by Vietnam, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the United States amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Brazil (X% per year) and Vietnam (X% per year).

Export Prices by Country

In 2022, the average human and animal blood export price amounted to $X per ton, growing by X% against the previous year. In general, the export price saw prominent growth. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Brazil ($X,180 per ton), while the average price for exports to Bangladesh ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United Arab Emirates (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Republic of Korea

In 2022, overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons, falling for the second year in a row after seven years of growth. Over the period under review, imports, however, recorded a moderate increase. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, human and animal blood imports shrank notably to $X in 2022. Overall, imports, however, saw a measured increase. The pace of growth was the most pronounced in 2018 when imports increased by X%. Imports peaked at $X in 2021, and then plummeted in the following year.

Imports by Country

In 2022, China (X tons) constituted the largest human and animal blood supplier to South Korea, with a X% share of total imports. Moreover, human and animal blood imports from China exceeded the figures recorded by the second-largest supplier, the United States (X tons), twofold. The third position in this ranking was held by Japan (X tons), with a X% share.

From 2012 to 2022, the average annual growth rate of volume from China stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and Japan (X% per year).

In value terms, the United States ($X) constituted the largest supplier of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to South Korea, comprising X% of total imports. The second position in the ranking was taken by Switzerland ($X), with a X% share of total imports. It was followed by China, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from the United States amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Switzerland (X% per year) and China (X% per year).

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2022, rising by X% against the previous year. Over the period under review, the import price, however, continues to indicate a slight slump. The most prominent rate of growth was recorded in 2021 an increase of X%. The import price peaked at $X per ton in 2013; however, from 2014 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Switzerland ($X,211 per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Canada (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :